These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3499953)

  • 1. Complement depletion suppresses Lewis rat experimental allergic neuritis.
    Feasby TE; Gilbert JJ; Hahn AF; Neilson M
    Brain Res; 1987 Sep; 419(1-2):97-103. PubMed ID: 3499953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis.
    Vriesendorp FJ; Flynn RE; Pappolla MA; Koski CL
    Int J Neurosci; 1997 Dec; 92(3-4):287-98. PubMed ID: 9522271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
    Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
    J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis.
    Vriesendorp FJ; Flynn RE; Malone MR; Pappolla MA
    Acta Neuropathol; 1998 Mar; 95(3):297-301. PubMed ID: 9542596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement depletion affects demyelination and inflammation in experimental allergic neuritis.
    Vriesendorp FJ; Flynn RE; Pappolla MA; Koski CL
    J Neuroimmunol; 1995 May; 58(2):157-65. PubMed ID: 7759605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early myelin lesions in experimental allergic neuritis.
    Rosen JL; Brown MJ; Hickey WF; Rostami A
    Muscle Nerve; 1990 Jul; 13(7):629-36. PubMed ID: 2388663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P0 myelin protein produces experimental allergic neuritis in Lewis rats.
    Milner P; Lovelidge CA; Taylor WA; Hughes RA
    J Neurol Sci; 1987 Jul; 79(3):275-85. PubMed ID: 2440998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of immune complexes in experimental allergic neuritis.
    Koh CS; Nakano T; Tsukada N; Yanagisawa N; Okano A; Taketomi T
    J Neurol Sci; 1984 Feb; 63(2):229-39. PubMed ID: 6368756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to transfer experimental allergic neuritis with lymphocytes.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    J Neuroimmunol; 1984; 6(6):373-85. PubMed ID: 6480819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of myelin P2 protein in the production of experimental allergic neuritis.
    Rostami A; Brown MJ; Lisak RP; Sumner AJ; Zweiman B; Pleasure DE
    Ann Neurol; 1984 Dec; 16(6):680-5. PubMed ID: 6084458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gangliosides on experimental allergic neuritis.
    Wiethölter H; Schabet M; Stevens A; Melms A; Sommer N; Weller M
    J Neuroimmunol; 1992 Jun; 38(3):221-8. PubMed ID: 1601979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental allergic neuritis with nedocromil sodium.
    Seeldrayers PA; Yasui D; Weiner HL; Johnson D
    J Neuroimmunol; 1989 Dec; 25(2-3):221-6. PubMed ID: 2479661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN.
    Wang YZ; Liang QH; Ramkalawan H; Zhang W; Zhou WB; Xiao B; Tian FF; Yang H; Li J; Zhang Y; Xu NA
    Immunol Invest; 2012; 41(2):171-82. PubMed ID: 21864114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to suppress experimental allergic neuritis in the rat by pretreatment with antigen.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    Acta Neuropathol; 1984; 64(2):153-60. PubMed ID: 6332448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis.
    Hadden RD; Gregson NA; Gold R; Smith KJ; Hughes RA
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):489-97. PubMed ID: 12445165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous chemiluminescence activity of peripheral blood cells during experimental allergic neuritis (EAN).
    Stevens A; Lang R; Schabet M; Wiethölter H; Hammann K
    J Neuroimmunol; 1990 Apr; 27(1):33-40. PubMed ID: 2318955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12.
    Calida DM; Kremlev SG; Fujioka T; Hilliard B; Ventura E; Constantinescu CS; Lavi E; Rostami A
    J Neuroimmunol; 2000 Jul; 107(1):1-7. PubMed ID: 10808045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelination of sciatic nerve in acute experimental allergic neuritis of the rat. A gel electrophoresis investigation.
    Schott K; Jenner A; Wiethölter H; Schabet M; Stevens A
    J Neuroimmunol; 1988 Nov; 20(1):53-61. PubMed ID: 3263390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.